Floatz logo

Enoxaparin

Anticoagulants

University of Utahother_biologicalPhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Anticoagulants cohort.

Asset / SponsorPhaseRating
BIVALIRUDIN
University of Texas Southwestern Medical Center
Phase 4BB
Acetylsalicylic Acid
University Hospital, Bordeaux
Phase 4BB
Plavix
University Hospital, Bordeaux
Phase 4BB
Unfractionated Heparin
University of Texas Southwestern Medical Center
Phase 4B
Apixaban
Pfizer
D

Same molecule, other indications

Enoxaparin is also rated in:

VTE (Venous Thromboembolism)Dormant
BBB
Indicative ·
78 / 100
View asset →
thrombophlebitisDormant
BBB
Indicative ·
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →